Approach To Prostate Cancer Treatment In Elderly Patients With High Comorbidity

The incidence of prostate cancer increases with age, and elderly patients often have other accompanying diseases. The most important clinical prediction for deciding on curative treatment in localized prostate cancer treatment is the 10-year survival status of the patient. In advanced prostate cancers, treatment is usually decided according to the comorbidity and age of the patients. Guidelines and consensus reports recommend that patients' general health status should be determined by validated health status screening forms in deciding on treatment for prostate cancer in elderly patients. After evaluating the health status, the treatment options recommended by the guidelines should be presented to the patients according to the risk group of the patient and the treatability of the existing diseases, regardless of their age. Patients who are found to be healthy as a result of the evaluation should be included in the standard treatment applied to non-elderly patients. For patients who are frail but have treatable disease, standard treatment is recommended after correction or improvement of comorbidities. Supportive treatment and adapted treatment options should be offered to the patients who are in a frail state.